News you can use: health & drug safety updates


  • August 17, 2010
    National Public Radio
  • August 5, 2010
    Southwest Review News
  • July 19, 2010
    The proportion of substance abuse treatment admissions of those aged 12 and older involving abuse of prescription pain relievers rose from 2.2% in 1998 to 9.8% in 2008, according to a new study from the Substance Abuse and Mental Health Services Administration (SAMHSA). The dramatic rise occurred among nearly all segments of the population regardless of age, gender, educational level and employment status.
  • June 30, 2010
    A hearing of the United States Special Committee on Aging convened on June 30th on the problem of unused medications and how to dispose of them. Chairman Kohl announced plans to work with members of the Committee to develop a comprehensive package of legislative reforms to reduce waste and ensure safe disposal of medications. Federal panelists included Gil Kerlikowske, Director, White House Office of National Drug Policy Control and Joseph Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, US Department of Justice.
  • June 30, 2010
    Med Ad News – page 26
  • June 30, 2010
    The Food and Drug Administration (FDA) has unveiled a new plan designed to curb the misuse of prescription opioids. The long-awaited and controversial Risk Evaluation and Mitigation Strategy (REMS) for long-acting and extended-release opioids includes mandatory prescriber and patient education. FDA has released the new plan in advance of an advisory committee meeting scheduled for July 22 and 23. They are seeking input from stakeholders and the public. The new proposal is advocating more oversight, but the FDA has dropped
  • June 23, 2010
    The National Council on Patient Information and Education (NCPIE), as a member of the National Council on Medication Error Reporting and Prevention, is participating in the National Alert Network (NAN) for Serious Medication Errors. The NAN has been activated for an urgent message on the potential for serious or fatal errors with epinephrine. Download the PDF for details on this NAN - Alert. Members of NCPIE are strongly advised to evaluate the risk for this error in their organizations and settings of care and implement their recommended
  • June 22, 2010
    The excesses of the Baby Boomer generation are starting to show up at the door of U.S. treatment programs, which saw admissions of patients ages 50 and older almost double between 1992 and 2008. Patients over age 50 comprised 12.2 percent of all treatment admissions in 2008, up from 6.6 percent in 1992. Admissions for heroin use among this age group more than doubled, cocaine admissions quadrupled, and significant increases in older Americans seeking treatment for prescription drugs and marijuana also were reported. More older
  • June 18, 2010
    The U.S. Food and Drug Administration (FDA) today warned consumers about a potentially harmful product represented as “Generic Tamiflu” sold over the Internet. FDA tests revealed that the fraudulent product does not contain Tamiflu’s active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin. FDA reminds patients who are allergic to or may have experienced adverse reactions from penicillin products that they are at risk of experiencing similar reactions from cloxacillin. This includes a sudden, potentially life-threatening
  • June 2, 2010
    Capping a decade-long effort by pharmacy and technology interests to modernize all facets of the prescription prescribing and dispensing process, the Drug Enforcement Administration (DEA) has struck down legal impediments to the electronic prescribing of controlled substances. In a June 1 announcement, the DEA issued its interim final rule allowing for the paperless prescribing of controlled substances. Publication of the new rule clears away the last barrier preventing doctors and pharmacists from shifting controlled medicines into information